Assignee
AMYLIN PHARMACEUTICALS INC
US·108 granted patents·27 pending applications·6,082 citations·filing 1989–2010
Top patents by PatentIndex Score
135 records- 0199US6924264B1Modified exendins and exendin agonistsAMYLIN PHARMACEUTICALS INC·Filed 2000·Granted Aug 2, 2005·169 cites·23 claims
- 0298US7928065B2Methods of treatment using exendin peptides or GLP-1 peptidesAMYLIN PHARMACEUTICALS INC·Filed 2008·Granted Apr 19, 2011·63 cites·45 claims
- 0398US7858740B2Exendin agonist compoundsAMYLIN PHARMACEUTICALS INC·Filed 2006·Granted Dec 28, 2010·39 cites·9 claims
- 0498US7691963B2Exendins and exendin agonists modified with polyamino acidsAMYLIN PHARMACEUTICALS INC·Filed 2008·Granted Apr 6, 2010·48 cites·20 claims
- 0598US7419952B2Use of exendins and agonists thereof to treat diabetesAMYLIN PHARMACEUTICALS INC·Filed 2006·Granted Sep 2, 2008·53 cites·20 claims
- 0698US7153825B2Methods for glucagon suppression using modified exendinsAMYLIN PHARMACEUTICALS INC·Filed 2005·Granted Dec 26, 2006·111 cites·35 claims
- 0798US6872700B1Methods for glucagon suppressionAMYLIN PHARMACEUTICALS INC·Filed 2000·Granted Mar 29, 2005·184 cites·24 claims
- 0898US6858576B1Methods for regulating gastrointestinal motilityAMYLIN PHARMACEUTICALS INC·Filed 1997·Granted Feb 22, 2005·211 cites·22 claims
- 0997US8026210B2Exendins and exendin agonist analogs to regulate gastrointestinal motilityAMYLIN PHARMACEUTICALS INC·Filed 2009·Granted Sep 27, 2011·43 cites·21 claims
- 1097US7741269B2Exendins and exendin agonists for weight reduction and obesityAMYLIN PHARMACEUTICALS INC·Filed 2004·Granted Jun 22, 2010·88 cites·44 claims
- 1197US7683030B2Methods of treating diabetes with albumin-conjugated exendin peptidesAMYLIN PHARMACEUTICALS INC·Filed 2008·Granted Mar 23, 2010·42 cites·15 claims
- 1297US7608692B2Exendins and exendin agonists modified with albuminAMYLIN PHARMACEUTICALS INC·Filed 2008·Granted Oct 27, 2009·43 cites·12 claims
- 1397US7521423B2Exendin pharmaceutical compositionsAMYLIN PHARMACEUTICALS INC·Filed 2004·Granted Apr 21, 2009·96 cites·32 claims
- 1497US7452858B2Treatment of gestational diabetesAMYLIN PHARMACEUTICALS INC·Filed 2005·Granted Nov 18, 2008·43 cites·19 claims
- 1597US7407932B2Methods for glucagon suppression using modified exendinsAMYLIN PHARMACEUTICALS INC·Filed 2006·Granted Aug 5, 2008·41 cites·7 claims
- 1697US7297761B2Pharmaceutical compositions containing exendinsAMYLIN PHARMACEUTICALS INC·Filed 2004·Granted Nov 20, 2007·114 cites·37 claims
- 1797US7157555B1Exendin agonist compoundsAMYLIN PHARMACEUTICALS INC·Filed 1998·Granted Jan 2, 2007·132 cites·4 claims
- 1897US7138375B2Use of exendins and agonists thereof for lowering plasma lipidAMYLIN PHARMACEUTICALS INC·Filed 2004·Granted Nov 21, 2006·95 cites·20 claims
- 1997US7115569B2Exendins, exendin agonists, and methods for their useAMYLIN PHARMACEUTICALS INC·Filed 2004·Granted Oct 3, 2006·114 cites·60 claims
- 2097US6989366B2Exendins, exendin agonists, and methods for their useAMYLIN PHARMACEUTICALS INC·Filed 2002·Granted Jan 24, 2006·111 cites·42 claims
- 2197US6982248B2Metabolic intervention with GLP-1 to improve the function of ischemic and reperfused tissueAMYLIN PHARMACEUTICALS INC·Filed 2001·Granted Jan 3, 2006·78 cites·28 claims
- 2297US6956026B2Use of exendins for the reduction of food intakeAMYLIN PHARMACEUTICALS INC·Filed 1998·Granted Oct 18, 2005·194 cites·68 claims
- 2397US6902744B1Exendin agonist formulations and methods of administration thereofAMYLIN PHARMACEUTICALS INC·Filed 2000·Granted Jun 7, 2005·180 cites·42 claims
- 2497US6706689B2Treatment of acute coronary syndrome with GLP-1AMYLIN PHARMACEUTICALS INC·Filed 2001·Granted Mar 16, 2004·142 cites·41 claims
- 2596US7700549B2Exendin agonist analogs to treat diabetesAMYLIN PHARMACEUTICALS INC·Filed 2008·Granted Apr 20, 2010·43 cites·18 claims
- 2696US7442680B2Inotropic and diuretic effects of GLP-1 and GLP-1 agonistsAMYLIN PHARMACEUTICALS INC·Filed 2003·Granted Oct 28, 2008·66 cites·16 claims
- 2796US6894024B2Treatment of hibernating myocardium and diabetic cardiomyopathy with a GLP-1 peptideAMYLIN PHARMACEUTICALS INC·Filed 2001·Granted May 17, 2005·91 cites·9 claims
- 2896US6703359B1Inotropic and diuretic effects of exendin and GLP-1AMYLIN PHARMACEUTICALS INC·Filed 1999·Granted Mar 9, 2004·160 cites·42 claims
- 2996US6506724B1Use of exendins and agonists thereof for the treatment of gestational diabetes mellitusAMYLIN PHARMACEUTICALS INC·Filed 1999·Granted Jan 14, 2003·177 cites·13 claims
- 3096US5686411AAmylin agonist peptides and uses thereforAMYLIN PHARMACEUTICALS INC·Filed 1995·Granted Nov 11, 1997·148 cites·45 claims
- 3195US7888314B2Compositions and methods for treating peripheral vascular diseaseAMYLIN PHARMACEUTICALS INC·Filed 2005·Granted Feb 15, 2011·22 cites·8 claims
- 3295US7696161B2Exendin agonist compoundsAMYLIN PHARMACEUTICALS INC·Filed 2007·Granted Apr 13, 2010·43 cites·48 claims
- 3395US7399489B2Exendin analog formulationsAMYLIN PHARMACEUTICALS INC·Filed 2005·Granted Jul 15, 2008·40 cites·36 claims
- 3495US7223725B1Exendin agonist compoundsAMYLIN PHARMACEUTICALS INC·Filed 1998·Granted May 29, 2007·83 cites·16 claims
- 3595US7056887B2Treatment of acute coronary syndrome with GLP-1AMYLIN PHARMACEUTICALS INC·Filed 2002·Granted Jun 6, 2006·59 cites·12 claims
- 3693US7879794B2Methods for controlling binge eating disordersAMYLIN PHARMACEUTICALS INC·Filed 2006·Granted Feb 1, 2011·28 cites·20 claims
- 3793US7259136B2Compositions and methods for treating peripheral vascular diseaseAMYLIN PHARMACEUTICALS INC·Filed 2002·Granted Aug 21, 2007·40 cites·11 claims
- 3893US7105489B2Methods and compositions for treating polycystic ovary syndromeAMYLIN PHARMACEUTICALS INC·Filed 2002·Granted Sep 12, 2006·52 cites·20 claims
- 3993US6114304AMethods for regulating gastrointestinal motilityAMYLIN PHARMACEUTICALS INC·Filed 1994·Granted Sep 5, 2000·103 cites·35 claims
- 4093US6087334AAnti-diabetic peptidesAMYLIN PHARMACEUTICALS INC·Filed 1998·Granted Jul 11, 2000·118 cites·82 claims
- 4192US7960341B2Methods and compositions for treating polycystic ovary syndromeAMYLIN PHARMACEUTICALS INC·Filed 2006·Granted Jun 14, 2011·16 cites·10 claims
- 4292US7723471B2Pancreatic polypeptide family motifs, polypeptides and methods comprising the sameAMYLIN PHARMACEUTICALS INC·Filed 2005·Granted May 25, 2010·18 cites·53 claims
- 4392US7271238B2Amylin agonist peptides and uses thereforAMYLIN PHARMACEUTICALS INC·Filed 2003·Granted Sep 18, 2007·22 cites·19 claims
- 4492US7220721B1Exendin agonist peptidesAMYLIN PHARMACEUTICALS INC·Filed 1998·Granted May 22, 2007·92 cites·75 claims
- 4592US7105490B2Methods and compositions for treating polycystic ovary syndromeAMYLIN PHARMACEUTICALS INC·Filed 2003·Granted Sep 12, 2006·35 cites·71 claims
- 4691US7981861B2Method of performing angioplasty with a GLP-1 moleculeAMYLIN PHARMACEUTICALS INC·Filed 2010·Granted Jul 19, 2011·14 cites·8 claims
- 4791US7906146B2Lyophilized formulations of exendins and exendin agonist analogsAMYLIN PHARMACEUTICALS INC·Filed 2009·Granted Mar 15, 2011·14 cites·20 claims
- 4891US7118737B2Polymer-modified synthetic proteinsAMYLIN PHARMACEUTICALS INC·Filed 2001·Granted Oct 10, 2006·60 cites·62 claims
- 4991US6998387B1Human appetite control by glucagon-like peptide receptor binding compoundsAMYLIN PHARMACEUTICALS INC·Filed 1999·Granted Feb 14, 2006·160 cites·19 claims
- 5091US5266561ATreatment of type 2 diabetes mellitusAMYLIN PHARMACEUTICALS INC·Filed 1991·Granted Nov 30, 1993·71 cites·4 claims
Showing the top 50 of 135 patent records by PatentIndex Score.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →